June 30(Reuters) - Japan Medical Dynamic Marketing Inc <7600.T>:Says its U.S.-based unit Ortho Development Corporation signed an exclusive distribution agreement with China-based firm China Pioneer Pharma Holdings Ltd <<<1345.HK>>>, regarding sales of artificial knee joint products produced by Ortho Development, in China.
June 30 (Reuters) - BACTIGUARD HOLDING AB ::NEW MAJOR ORDER FROM CHINA.RECEIVED A THIRD MAJOR ORDER FROM CHINA OF 100,000 BACTIGUARD COATED FOLEY CATHETERS.ORDER WILL BE DELIVERED IN JUNE AND GENERATE REVENUES OF SOME SEK 3 MILLION.
June 27 (Reuters) - BACTIGUARD HOLDING AB ::BACTIGUARD WINS ANOTHER TENDER IN SWEDEN.CONTRACT RUNS FROM AUGUST THIS YEAR TO APRIL 2018, WITH OPTION TO EXTEND IT ON AN ANNUAL BASIS..CONTRACT INITIALLY RUNS UNTIL 30 APRIL 2018 AND CAN BE EXTENDED ON AN ANNUAL BASIS UNTIL 30 APRIL 2020.
June 26(Reuters) - Wuhan Thalys Medical Technology Inc <603716.SS> ::* Says its unit signed service contract with Yichun People's Hospital for reagent and concentralized distribution.
June 16 (Reuters) - Medovex Corp ::Medovex Corporation receives first three commercial orders for DenerveX(tm) system.Has received its first three commercial orders for its DenerveX system.First commercial orders of DenerveX system included both DenerveX kit containing DenerveX device, DenerveX pro-40 generators for Germany, UK, Italy.
June 14(Reuters) - Green Cross Medical Science Corp <142280.KQ> ::* Says it signed 23.14 billion won contract to provide NAT reagent.
June 12 (Reuters) - Medovex Corp :Medovex Corp - three centers in EU will perform first in human cases for denervex system.Medovex - since receiving CE mark, have received orders for denervex kits and denervex pro-40 generators from TCB distribution center in Berlin.Medovex - since receiving CE mark have received orders from TCB Ortho, Germany distributor and Edge Medical in Manchester, England.
June 12 (Reuters) - Trovagene Inc :Trovagene enters into agreement with astrazeneca to utilize trovera® ctdna test and services in prospective biomarker study.Trovagene Inc - has entered into an agreement with astrazeneca to provide trovera® urine ctdna biomarker test and services.Trovagene Inc - trovera egfr urine liquid biopsy test will initially be used in an open label prospective biomarker study.
June 1 (Reuters) - BLUELINEA SA :TAKES OVER DIRECT SALES ACTIVITY TO INDIVIDUALS FOR SANTÉ SERVICE.THIS REPRESENTS AROUND EUR 800,000 IN ADDITIONAL RECURRENT B2C REVENUE OVER 12 MONTHS.